Global Prevalence of Child Myopia Is Increasing
WEDNESDAY, Sept. 25, 2024 -- The global prevalence of child myopia is increasing and is projected to reach 39.80 percent in 2050, according to a systematic review and meta-analysis published online Sept. 24 in the British Journal of Ophthalmology.
Jinghong Liang, from Sun Yat-Sen University in Guangzhou, China, and colleagues conducted a literature review to examine the global and regional prevalence of myopia and its occurrence within specific demographic groups. The analysis included 276 studies, with 5,410,945 children or adolescents from 50 countries in six continents.
The researchers observed a gradual increase in the pooled prevalence of myopia, varying from 24.32 to 35.81 percent from 1990 to 2023; prevalence is projected to reach 36.59 and 39.80 percent in 2040 and 2050, respectively. A higher proportion of myopia prevalence is exhibited in individuals residing in East Asia (35.22 percent) or in urban areas (28.55 percent) and in females, adolescents, and high school students (33.57, 47.00, and 45.71 percent, respectively).
"It is crucial to recognize that myopia may become a global health burden in the future," the authors write. "To address this growing epidemic, further research with a more region-specific approach is required to develop effective strategies at the local level."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis
TUESDAY, Sept. 2, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduction in the risk for developing uveitis, according to a study published...
Omega-3 PUFA Intake May Be Protective Against Myopia
MONDAY, Aug. 25, 2025 -- Omega-3 polyunsaturated fatty acid (ω-3 PUFA) intake may be protective against myopia in children, according to a study published online Aug. 19 in...
FDA Approves Vizz Eye Drops to Improve Near Vision in Adults
TUESDAY, Aug. 5, 2025 -- The U.S. Food and Drug Administration has approved Vizz 1.44 percent (aceclidine ophthalmic solution) for the treatment of presbyopia in adults. Vizz is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.